Health Cor Management, L.P. Incyte Corp Transaction History

Health Cor Management, L.P.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $415,544 - $520,277	-6,279 Reduced 2.68%	227,851 $15.2 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $17.6 Million - $22.1 Million	-266,270 Reduced 53.21%	234,130 $17.8 Million
Q1 2022 May 16, 2022	BUY	$66.02 - $79.71 $25.9 Million - $31.3 Million	392,350 Added 363.12%	500,400 $39.7 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $2.09 Million - $2.45 Million	33,050 Added 44.07%	108,050 $7.93 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $73.4 Million - $89.8 Million	-1,069,287 Reduced 93.45%	75,000 $5.16 Million
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $85.5 Million - $113 Million	1,124,757 Added 5759.12%	1,144,287 $93 Million
Q4 2020 Feb 16, 2021	SELL	$80.74 - $97.7 $246,256 - $297,985	-3,050 Reduced 13.51%	19,530 $1.7 Million
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $1.92 Million - $2.48 Million	22,580 New	22,580 $2.03 Million
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $7.97 Million - $11 Million	-130,910 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $101 Million - $123 Million	-1,219,090 Reduced 90.3%	130,910 $10.9 Million
Q4 2017 Feb 14, 2018	BUY	$93.56 - $116.6 $70.3 Million - $87.6 Million	751,450 Added 125.55%	1,350,000 $128 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $65.3 Million - $82.8 Million	598,550	598,550 $69.9 Million

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.